menu ☰
menu ˟

FDA approves Duzallo for treatment of hyperuricemia in patients with uncontrolled gout

21 Aug 2017
The FDA has approved Ironwood Pharmaceuticals’ Duzallo, a combination pill of lesinurad and allopurinol, for the treatment of hyperuricemia in patients with uncontrolled gout, according to a company press release.“The approval of Duzallo provides...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.